TrialBlood2016

CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.

James R Berenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.